Digital transformation has arrived in the pharmaceutical industry, and it’s the way of the future. Embracing the next wave of digital transformation is a must for pharmaceutical companies today. Despite initial hesitation around adopting next-gen…
Read more
Over the last 15 years, there has been a shift in the healthcare industry from the traditional fee-for-service model to value-based contracts. Rather than paying for healthcare services based only on the number of services…
Read more
Pharmaceutical companies are increasingly investing in patient support programs designed to increase engagement, optimize medication use, and achieve better individual health outcomes. However, not all patient outreach is effective, and getting it right is essential…
Read more
Rare diseases: although statistically uncommon, their burden is significant. Between 25 and 30 million Americans live with rare diseases. These diseases include cystic fibrosis, muscular dystrophy, sickle cell disease, hemophilia, and as many as 7,000 other…
Read more
Pharmaceutical companies spend more than $5 billion on patient support programs each year, but only 3 percent of patients actually use them. So what gives? What does an effective patient support program look like, and…
Read more
In the digital age, we have access to more data than ever before. Companies of all shapes and sizes use data to make smarter business decisions, manage budgets, improve efficiency, meet customer expectations, and more.…
Read more
The patient journey is paramount in healthcare today. Newly emerging technologies, shifting industry dynamics, and evolving consumer preferences are reshaping what the modern patient experience should look like. That’s why more and more healthcare organizations…
Read more
These days, nearly everything is driven by data in one way or another. Data empowers us to make better, more strategic decisions in many areas of life. Now, we are seeing more and more how…
Read more